Filing Details

Accession Number:
0001209191-18-013184
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2018-02-23 20:02:05
Reporting Period:
2018-01-04
Accepted Time:
2018-02-23 20:02:05
Original Submission Date:
2018-01-05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352238 Louis David Johnson C/O Dynavax Technologies
2929 Seventh Street, Suite 100
Berkeley CA 94710
Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-01-04 1,908 $18.60 5,728 No 4 F Direct
Common Stock Disposition 2018-01-04 3,092 $18.60 2,636 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. The reporting person is reporting the withholding by Dynavax Technologies Corporation of 1,908 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on January 2, 2018.